105 related articles for article (PubMed ID: 24193153)
1. Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients.
Okafor PN; Stallwood CG; Nguyen L; Sahni D; Wasan SK; Farraye FA; Erim DO
Inflamm Bowel Dis; 2013 Dec; 19(13):2787-95. PubMed ID: 24193153
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
[TBL] [Abstract][Full Text] [Related]
4. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.
Gordon LG; Rowell D
Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375
[TBL] [Abstract][Full Text] [Related]
5. Cost of nonmelanoma skin cancer treatment in the United States.
Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
[TBL] [Abstract][Full Text] [Related]
6. Occupational exposure to arsenic and risk of nonmelanoma skin cancer in a multinational European study.
Surdu S; Fitzgerald EF; Bloom MS; Boscoe FP; Carpenter DO; Haase RF; Gurzau E; Rudnai P; Koppova K; Févotte J; Vahter M; Leonardi G; Goessler W; Kumar R; Fletcher T
Int J Cancer; 2013 Nov; 133(9):2182-91. PubMed ID: 23595521
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease.
Cipriano LE; Levesque BG; Zaric GS; Loftus EV; Sandborn WJ
Inflamm Bowel Dis; 2012 Jul; 18(7):1240-8. PubMed ID: 21928375
[TBL] [Abstract][Full Text] [Related]
8. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
Peyrin-Biroulet L; Khosrotehrani K; Carrat F; Bouvier AM; Chevaux JB; Simon T; Carbonnel F; Colombel JF; Dupas JL; Godeberge P; Hugot JP; Lémann M; Nahon S; Sabaté JM; Tucat G; Beaugerie L;
Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and economic burden of nonmelanoma skin cancer.
Cakir BÖ; Adamson P; Cingi C
Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
[TBL] [Abstract][Full Text] [Related]
10. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
11. Subsequent nonmelanoma skin cancer after liver transplantation.
Herrero JI; España A; D'Avola D; Pardo F; Iñarrairaegui M; Rotellar F; Sangro B; Quiroga J
Transplant Proc; 2012; 44(6):1568-70. PubMed ID: 22841216
[TBL] [Abstract][Full Text] [Related]
12. Cost-utility Analysis: Thiopurines Plus Endoscopy-guided Biological Step-up Therapy is the Optimal Management of Postoperative Crohn's Disease.
Candia R; Naimark D; Sander B; Nguyen GC
Inflamm Bowel Dis; 2017 Nov; 23(11):1930-1940. PubMed ID: 29019856
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation.
Negrón ME; Kaplan GG; Barkema HW; Eksteen B; Clement F; Manns BJ; Coward S; Panaccione R; Ghosh S; Heitman SJ
Inflamm Bowel Dis; 2014 Nov; 20(11):2046-55. PubMed ID: 25230162
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population.
Javadinasab H; Daroudi R; Salimzadeh H; Delavari A; Vezvaie P; Malekzadeh R
Arch Iran Med; 2017 Sep; 20(9):564-571. PubMed ID: 29048918
[TBL] [Abstract][Full Text] [Related]
15. Nonmelanoma skin cancer and risk for subsequent malignancy.
Chen J; Ruczinski I; Jorgensen TJ; Yenokyan G; Yao Y; Alani R; Liégeois NJ; Hoffman SC; Hoffman-Bolton J; Strickland PT; Helzlsouer KJ; Alberg AJ
J Natl Cancer Inst; 2008 Sep; 100(17):1215-22. PubMed ID: 18728282
[TBL] [Abstract][Full Text] [Related]
16. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
[TBL] [Abstract][Full Text] [Related]
17. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
[TBL] [Abstract][Full Text] [Related]
18. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
[TBL] [Abstract][Full Text] [Related]
19. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
[TBL] [Abstract][Full Text] [Related]
20. Nonmelanoma skin cancer.
Dubas LE; Ingraffea A
Facial Plast Surg Clin North Am; 2013 Feb; 21(1):43-53. PubMed ID: 23369588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
